- Public Comps
- Cresco Labs
Cresco Labs Valuation Multiples
Discover Cresco Labs' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like SNDL, Verano Holdings, TerrAscend, High Tide and more.
Cresco Labs Overview
About Cresco Labs
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others. The company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.
Founded
1990
HQ

Employees
2.9K
Website
Financials (LTM)
EV
$857M
Valuation Multiples
Start free trialCresco Labs Financials
Cresco Labs reported last 12-month revenue of $655M and EBITDA of $150M.
In the same LTM period, Cresco Labs generated $325M in gross profit, $150M in EBITDA, and had net loss of ($90M).
Revenue (LTM)
Cresco Labs P&L
In the most recent fiscal year, Cresco Labs reported revenue of $656M and EBITDA of $157M.
Cresco Labs is unprofitable as of last fiscal year, with gross margin of 49%, EBITDA margin of 24%, and net margin of (21%).
Financial data powered by Morningstar, Inc.
Cresco Labs Stock Performance
Cresco Labs has current market cap of $303M, and enterprise value of $857M.
Market Cap Evolution
Cresco Labs' stock price is $0.82.
Cresco Labs share price decreased by 10.6% in the last 30 days, and increased by 59.7% in the last year.
Cresco Labs has an EPS (earnings per share) of $-0.37.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $857M | $303M | 0.9% | -10.6% | -6.7% | 59.7% | $-0.37 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCresco Labs Valuation Multiples
Cresco Labs trades at 1.3x EV/Revenue multiple, and 5.7x EV/EBITDA.
EV / Revenue (LTM)
Cresco Labs Financial Valuation Multiples
As of June 30, 2026, Cresco Labs has market cap of $303M and EV of $857M.
Cresco Labs has a P/E ratio of (3.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cresco Labs Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Cresco Labs Margins & Growth Rates
Cresco Labs decreased revenue by 0% and EBITDA by 9% in the last fiscal year.
In the most recent fiscal year, Cresco Labs reported gross margin of 49%, EBITDA margin of 24%, and net margin of (21%).
Cresco Labs Margins
Cresco Labs Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cresco Labs Operational KPIs
Cresco Labs' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Cresco Labs' Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cresco Labs' Rule of X is 21% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Cresco Labs Competitors
Cresco Labs competitors include SNDL, Verano Holdings, TerrAscend, High Tide, Canopy Growth, Aurora Cannabis, Vireo Growth, Organigram Global, Cannara Biotech and Jushi Holdings.
Most Cresco Labs public comparables operate across Cannabis, CannaTech and ViceTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.5x | 0.5x | 6.3x | 6.9x | |||
| 1.0x | - | (7.2x) | - | |||
| 1.6x | - | 7.1x | - | |||
| 0.7x | 0.6x | 10.1x | 8.2x | |||
| 1.8x | 1.7x | (25.2x) | (31.8x) | |||
| 0.5x | 0.5x | 3.0x | 3.5x | |||
| 2.7x | 1.5x | 9.6x | 5.7x | |||
| 0.8x | 0.6x | 10.8x | 9.4x | |||
This data is available for Pro users. Sign up to see all Cresco Labs competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Cresco Labs
Cresco Labs has acquired 4 companies to date.
Last acquisition by Cresco Labs was on October 14th 2021. Cresco Labs acquired Laurel Harvest for $80M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Cresco Labs
| Description | Laurel Harvest Labs is a Hagerstown, Maryland-based medical marijuana dispensary emphasizing patient care. It dispenses cannabis flower, edibles, tinctures, and topicals from licensed growers, with services including consultations for conditions like chronic pain and anxiety under Maryland's Medical Cannabis Program. | Cultivate is a Leicester, Massachusetts-based cannabis dispensary founded in 2017 that sells medical and recreational products. It sources and produces high-quality flower, edibles, and concentrates, serving customers through its retail location and delivery services in Central Massachusetts. | Bluma Wellness is a vertically integrated medical cannabis company licensed in Canada for cultivation, processing, and distribution. It produces dried flower, oils, and edibles through facilities in Ontario, supplying dispensaries and pharmacies across provinces with THC and CBD products compliant with Health Canada regulations. | Origin House is an Ottawa-headquartered cannabis company operating in Canada and the United States with a focus on branded products. Established in 2015, it distributes over 130 cannabis brands including edibles, vapes, and flower to dispensaries across California. Origin House supplies the majority of licensed retailers in the world's largest regulated market. The firm expands internationally through licensing and production partnerships. |
| HQ Country | ||||
| HQ City | Philadelphia, PA | - | Fort Lauderdale, FL | Ottawa |
| Deal Date | 14 Oct 2021 | 18 Mar 2021 | 14 Jan 2021 | 1 Apr 2019 |
| Valuation | $80M | $160M | $213M | $428M |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Cresco Labs acquisitions and their M&A valuation multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cresco Labs
| When was Cresco Labs founded? | Cresco Labs was founded in 1990. |
| Where is Cresco Labs headquartered? | Cresco Labs is headquartered in United States. |
| How many employees does Cresco Labs have? | As of today, Cresco Labs has over 2K employees. |
| Is Cresco Labs publicly listed? | Yes, Cresco Labs is a public company listed on OTCM. |
| What is the stock symbol of Cresco Labs? | Cresco Labs trades under CRLBF ticker. |
| Who are competitors of Cresco Labs? | Cresco Labs main competitors include SNDL, Verano Holdings, TerrAscend, High Tide, Canopy Growth, Aurora Cannabis, Vireo Growth, Organigram Global, Cannara Biotech, Jushi Holdings. |
| What is the current market cap of Cresco Labs? | Cresco Labs' current market cap is $303M. |
| What is the current revenue of Cresco Labs? | Cresco Labs' last 12 months revenue is $655M. |
| What is the current revenue growth of Cresco Labs? | Cresco Labs revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Cresco Labs? | Current revenue multiple of Cresco Labs is 1.3x. |
| What is the current EBITDA of Cresco Labs? | Cresco Labs' last 12 months EBITDA is $150M. |
| What is Cresco Labs' EBITDA margin? | Cresco Labs' last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Cresco Labs? | Current EBITDA multiple of Cresco Labs is 5.7x. |
| What is the current FCF of Cresco Labs? | Cresco Labs' last 12 months FCF is $2M. |
| What is Cresco Labs' FCF margin? | Cresco Labs' last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Cresco Labs? | Current FCF multiple of Cresco Labs is 427.8x. |
| How many companies Cresco Labs has acquired to date? | As of June 2026, Cresco Labs has acquired 4 companies. |
| What was the largest acquisition by Cresco Labs? | $428M acquisition of Origin House on 1st April 2019 was the largest M&A Cresco Labs has done to date. |
| What companies Cresco Labs acquired? | Cresco Labs acquired Origin House, Bluma Wellness, Cultivate, and Laurel Harvest. |
| In how many companies Cresco Labs has invested to date? | Cresco Labs hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Cresco Labs
Lists including Cresco Labs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.






